BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36384728)

  • 1. A study of congenital generalized lipodystrophy (CGL) caused by BSCL2 gene mutation.
    Ye JY; Huang AJ; Fu ZZ; Gong YY; Yang HY; Zhou HW
    Yi Chuan; 2022 Oct; 44(10):926-936. PubMed ID: 36384728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations.
    Mori E; Fujikura J; Noguchi M; Nakao K; Matsubara M; Sone M; Taura D; Kusakabe T; Ebihara K; Tanaka T; Hosoda K; Takahashi K; Asaka I; Inagaki N; Nakao K
    Metabolism; 2016 Apr; 65(4):543-56. PubMed ID: 26975546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two Japanese infants with congenital generalized lipodystrophy due to BSCL2 mutations.
    Nishiyama A; Yagi M; Awano H; Okizuka Y; Maeda T; Yoshida S; Takeshima Y; Matsuo M
    Pediatr Int; 2009 Dec; 51(6):775-9. PubMed ID: 19438831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy.
    Agarwal AK; Simha V; Oral EA; Moran SA; Gorden P; O'Rahilly S; Zaidi Z; Gurakan F; Arslanian SA; Klar A; Ricker A; White NH; Bindl L; Herbst K; Kennel K; Patel SB; Al-Gazali L; Garg A
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4840-7. PubMed ID: 14557463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel compound heterozygous variant of BSCL2 identified by whole exome sequencing and multiplex ligation‑dependent probe amplification in an infant with congenital generalized lipodystrophy.
    Xie B; Fan X; Lei Y; Yi S; Yang Q; Wang J; Qin Z; Shen F; Luo J; Shen Y
    Mol Med Rep; 2020 Jun; 21(6):2296-2302. PubMed ID: 32236581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel BSCL2 gene mutation E189X in Chinese congenital generalized lipodystrophy child with early onset diabetes mellitus.
    Jin J; Cao L; Zhao Z; Shen S; Kiess W; Zhi D; Ye R; Cheng R; Chen L; Yang Y; Luo F
    Eur J Endocrinol; 2007 Dec; 157(6):783-7. PubMed ID: 18057387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seipin ablation in mice results in severe generalized lipodystrophy.
    Cui X; Wang Y; Tang Y; Liu Y; Zhao L; Deng J; Xu G; Peng X; Ju S; Liu G; Yang H
    Hum Mol Genet; 2011 Aug; 20(15):3022-30. PubMed ID: 21551454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Seipin in Human Diseases and Experimental Animal Models.
    Li Y; Yang X; Peng L; Xia Q; Zhang Y; Huang W; Liu T; Jia D
    Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion mutation in BSCL2 gene underlies congenital generalized lipodystrophy in a Pakistani family.
    Rahman OU; Khawar N; Khan MA; Ahmed J; Khattak K; Al-Aama JY; Naeem M; Jelani M
    Diagn Pathol; 2013 May; 8():78. PubMed ID: 23659685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ablation of
    Mcilroy GD; Mitchell SE; Han W; Delibegović M; Rochford JJ
    Dis Model Mech; 2020 Jan; 13(1):. PubMed ID: 31848133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neonatal onset diabetes mellitus of Chinese neonate with congenital generalized lipodystrophy 2: a case report.
    Yang Y; Ma L; Sun J; Gong X; Cai C; Hong W
    BMC Endocr Disord; 2022 Mar; 22(1):83. PubMed ID: 35351089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metreleptin Treatment in a Boy with Congenital Generalized Lipodystrophy due to Homozygous c.465_468delGACT (p.T156Rfs*8) Mutation in the
    Özalkak Ş; Demiral M; Ünal E; Taş FF; Onay H; Demirbilek H; Özbek MN
    J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):329-333. PubMed ID: 35735786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic basis of congenital generalized lipodystrophy.
    Agarwal AK; Barnes RI; Garg A
    Int J Obes Relat Metab Disord; 2004 Feb; 28(2):336-9. PubMed ID: 14557833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene and phenotype analysis of congenital generalized lipodystrophy in Japanese: a novel homozygous nonsense mutation in seipin gene.
    Ebihara K; Kusakabe T; Masuzaki H; Kobayashi N; Tanaka T; Chusho H; Miyanaga F; Miyazawa T; Hayashi T; Hosoda K; Ogawa Y; Nakao K
    J Clin Endocrinol Metab; 2004 May; 89(5):2360-4. PubMed ID: 15126564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards a mechanistic understanding of lipodystrophy and seipin functions.
    Wee K; Yang W; Sugii S; Han W
    Biosci Rep; 2014 Oct; 34(5):. PubMed ID: 25195639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital generalized lipodystrophy in an Indian patient with a novel mutation in BSCL2 gene.
    Shirwalkar HU; Patel ZM; Magre J; Hilbert P; Van Maldergem L; Mukhopadhyay RR; Maitra A
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S317-22. PubMed ID: 18690553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 congenital generalized lipodystrophy with a heterozygous missense NOTCH2 mutation.
    Wang M; Cun Z; Peng J; Chen R; Li J
    Eur J Clin Nutr; 2022 Jul; 76(7):1041-1043. PubMed ID: 35043011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygous deletion of Seipin in islet beta cells of male mice has an impact on insulin synthesis and secretion through reduced PPARγ expression.
    Xiong J; Sun P; Wang Y; Hua X; Song W; Wang Y; Wu J; Yu W; Liu G; Chen L
    Diabetologia; 2020 Feb; 63(2):338-350. PubMed ID: 31776610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seipin: from human disease to molecular mechanism.
    Cartwright BR; Goodman JM
    J Lipid Res; 2012 Jun; 53(6):1042-55. PubMed ID: 22474068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic heterogeneity in body fat distribution in patients with congenital generalized lipodystrophy caused by mutations in the AGPAT2 or seipin genes.
    Simha V; Garg A
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5433-7. PubMed ID: 14602785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.